Dedicated kidney disease-focused outcome trials with sodium-glucose cotransporter-2 inhibitors: Lessons from CREDENCE and expectations from DAPA-HF, DAPA-CKD, and EMPA-KIDNEY
Type of Publication
Journal Article
Year of Publication
2020
Journal
Diabetes, Obesity and Metabolism
Language
Eng
Volume
22
Number of Pages
46 - 54
Links to full text